PT3188740T - Ativação de linfócitos infiltrantes de medula em condições hipóxicas em alternância com normóxicas - Google Patents
Ativação de linfócitos infiltrantes de medula em condições hipóxicas em alternância com normóxicasInfo
- Publication number
- PT3188740T PT3188740T PT158383588T PT15838358T PT3188740T PT 3188740 T PT3188740 T PT 3188740T PT 158383588 T PT158383588 T PT 158383588T PT 15838358 T PT15838358 T PT 15838358T PT 3188740 T PT3188740 T PT 3188740T
- Authority
- PT
- Portugal
- Prior art keywords
- hypoxic
- alternating
- activation
- infiltrating lymphocytes
- normoxic conditions
- Prior art date
Links
- 206010021143 Hypoxia Diseases 0.000 title 1
- 230000004913 activation Effects 0.000 title 1
- 230000001146 hypoxic effect Effects 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462045782P | 2014-09-04 | 2014-09-04 | |
| US201562186040P | 2015-06-29 | 2015-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3188740T true PT3188740T (pt) | 2021-06-23 |
Family
ID=55440392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT158383588T PT3188740T (pt) | 2014-09-04 | 2015-09-04 | Ativação de linfócitos infiltrantes de medula em condições hipóxicas em alternância com normóxicas |
Country Status (13)
| Country | Link |
|---|---|
| US (7) | US9687510B2 (pt) |
| EP (2) | EP3922254A1 (pt) |
| JP (2) | JP6865160B2 (pt) |
| KR (1) | KR20170067751A (pt) |
| CN (1) | CN107109364A (pt) |
| AU (2) | AU2015311761B2 (pt) |
| CA (1) | CA2959994C (pt) |
| DK (1) | DK3188740T3 (pt) |
| ES (1) | ES2877108T3 (pt) |
| IL (2) | IL250746B (pt) |
| MX (1) | MX2017002852A (pt) |
| PT (1) | PT3188740T (pt) |
| WO (1) | WO2016037054A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3154350B1 (en) | 2014-04-10 | 2024-03-27 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy |
| AU2015311761B2 (en) * | 2014-09-04 | 2020-11-12 | The Johns Hopkins University | Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions |
| MX2018000278A (es) * | 2015-06-29 | 2018-03-08 | Univ Johns Hopkins | Terapia de receptores quimericos de puntos de control inmunitarios. |
| MA42902A (fr) * | 2015-07-08 | 2018-05-16 | Univ Johns Hopkins | Lymphocytes infiltrant la moelle (mil) en tant que source de lymphocytes t pour une thérapie par des récepteurs chimériques d'un antigène (car) |
| TWI788307B (zh) | 2016-10-31 | 2023-01-01 | 美商艾歐凡斯生物治療公司 | 用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞 |
| MX2019005617A (es) | 2016-11-17 | 2019-08-14 | Iovance Biotherapeutics Inc | Linfocitos infiltrantes de tumores remanentes y metodos de preparacion y uso de los mismos. |
| KR20190096969A (ko) * | 2016-12-22 | 2019-08-20 | 윈드밀 테라퓨틱스, 인크. | 면역계를 조절하기 위한 조성물 및 방법 |
| WO2018129336A1 (en) | 2017-01-06 | 2018-07-12 | Iovance Biotherapeutics, Inc. | Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof |
| US11254913B1 (en) | 2017-03-29 | 2022-02-22 | Iovance Biotherapeutics, Inc. | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy |
| JOP20190224A1 (ar) | 2017-03-29 | 2019-09-26 | Iovance Biotherapeutics Inc | عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي |
| AU2019240420A1 (en) | 2018-03-22 | 2020-06-25 | Windmil Therapeutics, Inc. | Prostate cancer specific marrow infiltrating lymphocytes and uses thereof |
| US20210338730A1 (en) * | 2018-11-05 | 2021-11-04 | Windmil Therapeutics, Inc. | Marrow Infiltrating Lymphocytes With Increased Clonality and Uses Thereof |
| AU2019387242A1 (en) * | 2018-11-30 | 2021-06-03 | Windmil Therapeutics, Inc. | Marrow infiltrating lymphocytes (MILs) expressing chimeric antigen receptors (CAR), method of manufacturing same, and method of using in therapy |
| CN114072158A (zh) * | 2019-03-22 | 2022-02-18 | 温德弥尔治疗公司 | 肺癌特异性骨髓浸润淋巴细胞及其用途 |
| US20230100744A1 (en) * | 2020-02-28 | 2023-03-30 | Windmil Therapeutics, Inc. | Methods for enriching marrow infiltrating lymphocytes ("mils"), compositions containing enriched mils, and methods of using enriched mils |
| WO2022066872A1 (en) * | 2020-09-24 | 2022-03-31 | Windmil Therapeutics, Inc. | Marrow infiltrating lymphocytes (mils) expressing t cell receptors, methods of manufacturing same, and method of using in therapy |
| WO2023201369A1 (en) | 2022-04-15 | 2023-10-19 | Iovance Biotherapeutics, Inc. | Til expansion processes using specific cytokine combinations and/or akti treatment |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3243600A (en) | 1999-02-23 | 2000-09-14 | Kathleen S. Carswell | Improved method of culturing t cells |
| US6811788B2 (en) * | 2000-01-19 | 2004-11-02 | Baofa Yu | Combinations and methods for treating neoplasms |
| EP2111231A4 (en) * | 2007-02-13 | 2010-12-15 | Univ Northeastern | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES |
| WO2010062742A2 (en) * | 2008-11-03 | 2010-06-03 | The Johns Hopkins University | Methods for freparation and use of marrow infiltrating lymphocytes (mils) |
| BR112014007947A2 (pt) | 2011-10-03 | 2017-04-18 | Univ Los Andes | método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5 |
| EP2804625A4 (en) | 2012-01-17 | 2015-10-28 | Univ Northeastern | METHODS AND COMPOSITIONS FOR IN VITRO DEVELOPMENT OF IMMUNOSUPPRESSANT REGULATORS AND USES THEREOF |
| JP2014090678A (ja) * | 2012-11-01 | 2014-05-19 | Ito En Ltd | 容器詰野菜汁及び／又は果汁含有飲料及びその製造方法、並びに容器詰野菜汁及び／又は果汁含有飲料の呈味劣化防止方法 |
| PT2925329T (pt) * | 2012-11-27 | 2021-03-29 | Ivan Marques Borrello | Utilização de linfócitos infiltrantes de medula alogénica tratados com ciclofosfamida pós-transplante para aumentar a imunidade antitumoral |
| AU2015311761B2 (en) | 2014-09-04 | 2020-11-12 | The Johns Hopkins University | Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions |
| KR20190096969A (ko) * | 2016-12-22 | 2019-08-20 | 윈드밀 테라퓨틱스, 인크. | 면역계를 조절하기 위한 조성물 및 방법 |
| AU2019240420A1 (en) * | 2018-03-22 | 2020-06-25 | Windmil Therapeutics, Inc. | Prostate cancer specific marrow infiltrating lymphocytes and uses thereof |
| AU2019387242A1 (en) * | 2018-11-30 | 2021-06-03 | Windmil Therapeutics, Inc. | Marrow infiltrating lymphocytes (MILs) expressing chimeric antigen receptors (CAR), method of manufacturing same, and method of using in therapy |
-
2015
- 2015-09-04 AU AU2015311761A patent/AU2015311761B2/en active Active
- 2015-09-04 JP JP2017512293A patent/JP6865160B2/ja active Active
- 2015-09-04 EP EP21167891.7A patent/EP3922254A1/en not_active Withdrawn
- 2015-09-04 KR KR1020177009084A patent/KR20170067751A/ko active IP Right Grant
- 2015-09-04 WO PCT/US2015/048536 patent/WO2016037054A1/en active Application Filing
- 2015-09-04 MX MX2017002852A patent/MX2017002852A/es unknown
- 2015-09-04 ES ES15838358T patent/ES2877108T3/es active Active
- 2015-09-04 PT PT158383588T patent/PT3188740T/pt unknown
- 2015-09-04 DK DK15838358.8T patent/DK3188740T3/da active
- 2015-09-04 US US15/112,353 patent/US9687510B2/en active Active
- 2015-09-04 EP EP15838358.8A patent/EP3188740B1/en active Active
- 2015-09-04 CN CN201580059448.3A patent/CN107109364A/zh active Pending
- 2015-09-04 CA CA2959994A patent/CA2959994C/en active Active
-
2017
- 2017-02-23 IL IL250746A patent/IL250746B/en active IP Right Grant
- 2017-05-26 US US15/606,766 patent/US10406178B2/en active Active
- 2017-05-26 US US15/606,951 patent/US10172887B2/en active Active
-
2018
- 2018-12-03 US US16/207,864 patent/US11160830B2/en active Active
-
2019
- 2019-07-30 US US16/526,656 patent/US11406666B2/en active Active
-
2020
- 2020-07-28 IL IL276347A patent/IL276347B/en unknown
-
2021
- 2021-02-02 AU AU2021200648A patent/AU2021200648A1/en active Pending
- 2021-04-05 JP JP2021063957A patent/JP7197213B2/ja active Active
- 2021-09-30 US US17/490,691 patent/US20220016172A1/en active Pending
-
2022
- 2022-07-14 US US17/864,546 patent/US20230000919A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276347B (en) | Activation of infiltrating lymphocytes in hypoxic conditions alternating with conditions with normal oxygen concentration | |
| HK1254326A1 (zh) | 電動行李箱 | |
| IL246693B2 (en) | Antibody molecules to tim-3 and their uses | |
| SG11201703316UA (en) | Suspended load carrying system | |
| PL3099607T3 (pl) | Przenośnik indukcyjny | |
| EP2942914A4 (en) | CHARGE SHARING METHOD AND APPARATUS | |
| AU358473S (en) | Trolley | |
| AU201613057S (en) | Luggage with handle down | |
| HK1243685A1 (zh) | 一種運載物品的手推車 | |
| GB201521270D0 (en) | Trolley | |
| ZA201603952B (en) | Trolley structure capable of being combined with bicycle | |
| GB201500715D0 (en) | Improvements in and relating to zipwire trolleys | |
| GB2529250B (en) | Improvements in hinge assemblies | |
| GB201323132D0 (en) | New products and processes | |
| HUE045617T2 (hu) | Endotoxin felfedése oldatban | |
| IL235379A (en) | Magnesium containing products and their uses | |
| GB201413752D0 (en) | Trolley bag | |
| GB201421021D0 (en) | Improvements in luggage | |
| SG10202005396RA (en) | Set of devices with at least one trolley for operation in explosive environment | |
| GB201420885D0 (en) | Lifi application in aerospace | |
| GB201410302D0 (en) | Closed linear dna nanoparticles | |
| GB201518605D0 (en) | Bag with bag holding section | |
| GB2534939B (en) | Personal load carrying vest | |
| GB201420497D0 (en) | Pants with pockets | |
| GB201500802D0 (en) | Bag with carrying handle |